{
  "id": 13297813,
  "title": "Onemednet CFO Robert Golden sells $55,290 in shares",
  "url": "https://urgent.news/2026/10/10/onemednet-cfo-robert-golden-sells-55-290-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-10T02:01:09.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/onemednet-cfo-robert-golden-sells-55290-in-shares-93CH-4941936"
  },
  "original_language": "en",
  "account": "Onemednet CFO Robert Golden, Director of OneMedNet Corp (NASDAQ:ONMD), recently sold $55,290 worth of the company's common stock in September 2026. The transactions occurred on September 14, 15, and 21, with shares priced between $6.30 and $6.63 each. A total of 8,500 shares were sold as part of these transactions, aimed at covering tax obligations linked to the vesting and settlement of restricted stock units (RSUs). Earlier this year, Mr. Golden purchased 45,000 shares through RSU grants. He received 10,000 RSUs on January 1, 2026, which were expected to fully vest by December 31, 2026, under the terms of a consulting agreement. Additionally, he acquired 35,000 RSUs on July 6, 2026, with one-third vesting on the first anniversary of January 1, 2026, followed by equal quarterly installments over the subsequent 24 months, contingent upon his continued employment with the company. Each RSU grants the holder the right to acquire one share of OneMedNet's common stock. The RSU grants were initially valued at $0. Following the transactions disclosed in this filing, Mr. Golden now directly owns 91,291 shares of OneMedNet common stock. All share amounts and prices mentioned in this filing have been adjusted to account for a 1-for-10 reverse stock split executed by OneMedNet on September 29, 2026. The insider sales come as OneMedNet shares are trading at $4.30, marking their 52-week low after experiencing a 61% decline year-to-date. Despite the significant drop, InvestingPro analysis indicates that the stock remains undervalued relative to its Fair Value. The company's financial health rating is WEAK, with InvestingPro suggesting 11 additional tips for investors considering the stock's prospects.",
  "summary": null,
  "key_points": [
    "CFO Robert Golden sold $55,290 worth of OneMedNet shares in September 2026.",
    "Transactions occurred on September 14, 15, and 21 at prices between $6.30 and $6.63.",
    "Sale aimed to cover tax obligations for RSU vesting and settlement."
  ],
  "editors_take": "The sale of shares by OneMedNet's CFO to cover tax obligations linked to restricted stock units does not directly indicate a loss of confidence in the company, but rather a routine financial management step.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}